col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


27 Results       Page 1

 [1] 
Elsevier: Journal of Translational Autoimmunity
  original article Date Title Authors   All Authors
1 [GO] 2025―Apr―25 The changes in global burden of autoimmune diseases two years after the COVID-19 pandemic: a trend analysis based on the Global Burden of Disease Study 2021 Danting Zhang, Wanyu Hua, Fangfang Sun, Chao Wen, Lai Yee Cheong, Ruiyan Xie, et al. (+5)
2 [GO] 2025―Mar―06 Pediatric Autoimmune Diseases in the Light of COVID-19 Pandemic, A Retrospective Observational Big Data Study. Rim Kasem Ali Sliman, Hilla Cohen, Shereen Shehadeh, Reut Batcir, Yigal Elenberg Alter, Keren Cohen, et al. (+4)
3 [GO] 2025―Feb―21 NETosis: A key player in autoimmunity, COVID-19, and long COVID Diana M. Monsalve, Yeny Acosta-Ampudia, Nicolás Guerrero Acosta, Mariana Celis-Andrade, Ali Şahin, Ahsen Morva Yilmaz, et al. (+2)
4 [GO] 2024―Oct―25 Association of COVID-19 with Thyroid Dysfunction and Autoimmune Thyroid Disease: A Retrospective Cohort Study Jia Di, Xiaodong Ma, Tao Wu, Eryue Qiao, Mojtaba Salouti, Yu Zhong, et al. (+8)
5 [GO] 2023―Dec―12 Effect of traditional therapeutics on prevalence and clinical outcomes of coronavirus disease 2019 in Chinese patients with autoimmune diseases Saisai Huang, Xiaolei Ma, Juan Cao, Mengru Du, Zhiling Zhao, Dandan Wang, et al. (+3)
6 [GO] 2023―Nov―29 Impact of the COVID-19 pandemic on temporal trends of biological indicators of autoimmunity Elliott Van Regemorter, Giulia Zorzi, Anais Scohy, Damien Gruson, Johann Morelle
7 [GO] 2023―Nov―28 Long-term outcomes of COVID-19 vaccination in patients with rare and complex connective tissue diseases: The ERN-ReCONNET VACCINATE study Chiara Tani, Chiara Cardelli, Roberto Depascale, Anna Gamba, Luca Iaccarino, Andrea Doria, et al. (+37)
8 [GO] 2023―Oct―17 SARS-CoV-2 and thyroid diseases Małgorzata Staruszkiewicz, Anna Pituch-Noworolska, Szymon Skoczen
9 [GO] 2023―Oct―14 Role of autoantibodies targeting interferon type 1 in COVID-19 severity: A systematic review and meta-analysis Abolfazl Akbari, Alireza Hadizadeh, Mahdi Amiri, Neshat Najaf Najafi, Zahra Shahriari, Tannaz Jamialahmadi, Amirhossein Sahebkar
10 [GO] 2023―Oct―09 Impact of COVID-19 and vaccination campaign on 1,755 systemic sclerosis patients during first three years of pandemic. Possible risks for individuals with impaired immunoreactivity to vaccine, ongoing immunomodulating treatments, and disease-related lung involvement during the next pandemic phase Clodoveo Ferri, Vincenzo Raimondo, Dilia Giuggioli, Laura Gragnani, Serena Lorini, Lorenzo Dagna, et al. (+67)
11 [GO] 2023―Apr―06 Glucocorticoids selectively affect the memory T cell response to SARS-Cov2 spike in vaccinated and post-infected patients with systemic lupus erythematosus Yves Renaudineau, Chloé Bost, Florence Abravanel, Jacques Izopet, Antoine Blancher, Nicolas Congy, et al. (+2)
12 [GO] 2023―Jan―14 COVID-19 presentation and outcomes in patients with inflammatory rheumatic and musculoskeletal diseases receiving IL6-receptor antagonists prior to SARS-CoV-2 infection Cloé Comarmond, Elodie Drumez, Julien Labreuche, Eric Hachulla, Thierry Thomas, René-Marc Flipo, et al. (+15)
13 [GO] 2022―Nov―25 Transient expression of antinuclear RNP-A antibodies in patients with acute COVID-19 infection Shuxia Zhou, Ravi Kaul, Kara L. Lynch, Alan H.B. Wu, Roger P. Walker
14 [GO] 2022―Sep―13 COVID-19 vaccine immunogenicity in 16 patients with autoimmune systemic diseases. Lack of both humoral and cellular response to booster dose and ongoing disease modifying therapies Laura Gragnani, Marcella Visentini, Serena Lorini, Francesca La Gualana, Stefano Angelo Santini, Fabio Cacciapaglia, et al. (+8)
15 [GO] 2022―Apr―13 SARS-Cov2 acute and post-active infection in the context of autoimmune and chronic inflammatory diseases Regina Larionova, K. Byvaltsev, Оlga Kravtsova, Elena Takha, Sergei Petrov, Gevorg Kazarian, et al. (+5)
16 [GO] 2022―Feb―25 A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases Julia Y. Wang, Michael W. Roehrl, Victor B. Roehrl, Michael H. Roehrl
17 [GO] 2022―Jan―04 COVID-19 vaccine and autoimmunity. A new case of autoimmune hepatitis and review of the literature Laura Camacho-Domínguez, Yhojan Rodríguez, Fernando Polo, Juan Carlos Restrepo Gutierrez, Elizabeth Zapata, Manuel Rojas, Juan-Manuel Anaya
18 [GO] 2021―Aug―31 Celiac disease in the COVID-19 pandemic Gabriel Samasca, Aaron Lerner
19 [GO] 2021―Aug―19 Immunogenicity of repeat COVID-19 mRNA vaccinations in a patient with myasthenia gravis receiving mycophenolate, prednisone, and eculizumab Lisa C. Plymate, Gregory Pepper, Maxwell P. Krist, David M. Koelle
20 [GO] 2021―Mar―23 Case study of a critically ill person with COVID-19 on ECMO successfully treated with leronlimab Sohier Elneil, Jacob P. Lalezari, Nader Z. Pourhassan
21 [GO] 2021―Mar―02 Latent Rheumatic, Thyroid and Phospholipid Autoimmunity in Hospitalized Patients with COVID-19 Juan-Manuel Anaya, Diana M. Monsalve, Manuel Rojas, Yhojan Rodríguez, Norma Montoya-García, Laura Milena Mancera-Navarro, et al. (+4)
22 [GO] 2021―Feb―16 Benefits of early aggressive immunomodulatory therapy (tocilizumab and methylprednisolone) in COVID-19: single center cohort study of 685 patients Buzón-Martín Luis, Montero-Baladía Miguel, Delgado-López Pedro, Iglesias-Posadilla David, Astigarraga Itziar, Galacho-Harriero Ana, et al. (+21)
23 [GO] 2021―Jan―29 Characteristics of COVID-19 infection and antibody formation in a Tertiary Immunology department N.A.D. Guchelaar, J.A.M. van Laar, M.A.W. Hermans, T.B. van der Houwen, S. Atmaca, M.S. van Maaren, et al. (+5)
24 [GO] 2021―Jan―10 Disruption of CCR5 signaling to treat COVID-19-associated cytokine storm: case series of four critically ill patients treated with leronlimab Nicholas Agresti, Jacob P. Lalezari, Phillip P. Amodeo, Kabir Mody, Steven F. Mosher, Harish Seethamraju, et al. (+11)
25 [GO] 2020―Nov―27 Prevalence of Autoantibody Responses in Acute Coronavirus Disease 2019 (COVID-19) L. Angelica Lerma, Anu Chaudhary, Andrew Bryan, Chihiro Morishima, Mark H. Wener, Susan L. Fink
26 [GO] 2020―Nov―05 Why will it never be known if convalescent plasma is effective for COVID-19 Manuel Rojas, Juan-Manuel Anaya
27 [GO] 2020―Apr―09 Pathogenic priming likely contributes to serious and critical illness and mortality in COVID-19 via autoimmunity James Lyons-Weiler
 [1] 

27 Results       Page 1


[de][en]

Last change 2025―Jul―29 14:55:09 UTC

© Daten-Quadrat 2022       Done in 0.009 sec